US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28

0.0000

Volume:- -

Turnover:- -

Market Cap:1.60M

PE:- -

High:53.28

Open:53.28

Low:53.28

Close:53.28

52wk High:56.90

52wk Low:44.36

Shares:30.00K

Float Shares:10.00K

Volume Ratio:2.68

T/O Rate:- -

Dividend:0.58

Dividend Rate:1.08%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Astrazeneca PLC Stock Falls Monday, Underperforms Market

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live

AstraZeneca PLC Stock (AZN) Moved Down by 3.79% on Jul 6: What Signal Does It Send?

AstraZeneca (AZN) Receives a Buy from Bernstein

CSPC Pharma Shares Surge Nearly 7% at Open on New $1.77 Billion Collaboration with AstraZeneca

Astrazeneca PLC Stock Rises Thursday, Outperforms Market

Multiple Companies Announce Positive Developments: CSPC Pharma Partners with AstraZeneca, Digital China Wins Major Mobile Server Contract

AstraZeneca Collaborating With CSPC Pharma in siRNA Drug Deal Worth Up to $1.77 Billion

MT Newswires Live

CSPC Innovation's Subsidiary Forges Strategic Alliance with AstraZeneca on Novel Extrabepatic siRNA Therapeutics

Astrazeneca to Collaborate With Abbisko Therapeutics for Potential Non-Small Cell Lung Cancer Treatment

MT Newswires Live

Biotech Firm Forges Major International Alliance with AstraZeneca! The Market's Sole Hang Seng Innovation Drug ETF, Huatai-PineBridge, Sees Turnover Exceed 10 Billion for 9 Consecutive Sessions

Abbisko-B Shares Surge Over 5% on Clinical Collaboration with AstraZeneca for NSCLC Treatment

AstraZeneca, Abbisko Therapeutics enter strategic collaboration

ABBISKO-B Unit Enters Strategic Collaboration with AstraZeneca for Clinical Study on First-in-Class Oral PD-L1 Inhibitor Combined with Tagrisso in Non-Small Cell Lung Cancer

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading

MT Newswires Live

AstraZeneca’s ASCERTAIN Trial Wrap-Up: What Prostate Cancer Data Could Mean for AZN Investors

Astrazeneca Slides Tuesday, Underperforms Market

Astrazeneca Might Face Questions About Next Year's Profitability

Deutsche Bank Remains a Sell on AstraZeneca (AZN)

AstraZeneca (AZN) Receives a Buy from Barclays

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/AZNH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1787342400000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"08-21 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":44.36,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649767817","title":"Astrazeneca PLC Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2649767817","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649767817?lang=en_us&edition=fundamental","pubTime":"2026-07-07 00:00","pubTimestamp":1783353600,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC dropped 2.7% to SEK1,813.00 Monday on what proved to be an overall negative trading session for the stock market, with the OMX Nordic 40 Index falling 0.7% to 2,738.65.This was the stock's second consecutive day of losses.The company closed SEK112.50 short of its 52-week high of SEK1,925.50, which the company reached on April 10, 2026.Trading volume was 190,542, compared to the 50-day average trading volume of 284,513.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 06, 2026 12:00 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU0029864427.USD","LU1829250122.USD","LU0310800379.SGD","LU2417539215.USD","LU2237443978.SGD","LU2237443465.HKD","BK4585","LU0708994859.HKD","LU0058720904.USD","IE00B3T34201.USD","LU2468319806.SGD","LU0432979614.USD","BK4588","LU0320765992.SGD","LU2237443549.SGD","LU2462157665.USD","LU2456880835.USD","LU2237443382.USD","LU2236285917.USD","LU2237443895.HKD","LU0889565916.HKD","LU0289739699.SGD","LU0109394709.USD","LU2089984988.USD","AZN","AZNH","LU0128525929.USD","LU1267930573.SGD","BK4007","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649025620","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2649025620","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649025620?lang=en_us&edition=fundamental","pubTime":"2026-07-06 23:21","pubTimestamp":1783351284,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking modestly higher late Monday morning, rising 0.33% to 1,919.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and semiconductor company Sequans Communications , which rose 5.3% and 5% respectively. They were followed by biotech firm Evaxion  and telecommunications company Ericsson , which were up 3.7% and 2.4% respectively.The decliners from continental Europe were led by biotech firm BioNTech  and pharmaceutical company Novo Nordisk , which fell 3% and 2.8% respectively. They were followed by brewing company Anheuser-Busch InBev  and consumer goods company Unilever , which were down 2.3% and 2.2% respectively.The gainers from the UK were led by biopharmaceutical company NuCana  and communications company WPP , which advanced 4.4% and 2.4% respectively. They were followed by lenders Barclays  and HSBC , which increased 1.5% and 1.4% resp","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4591","UL","AKTX","HSBH","NVO","DAVA","THNR","OZEM","LU0029864427.USD","NVO.AU","NVOX","HSBC","BCS","BK4505","LU0124676726.USD","LU0689626769.HKD","AZNH","LU2237443622.USD","LU0006061336.USD","EVAX","IEUR","NVOH","NCNA","EPV","BK4554","UN","AZN","BK7119","LU2237443978.SGD","ERIC","BUD","BUD.AU","WPP","LU2456880835.USD","BK4588","WPP.AU","BNTX","BK4134","MREO","SQNS","LU2089984988.USD","AFG","DAVA.AU","IE00BMPRXR70.SGD","LNOK","LU0289739699.SGD","NOK","LU1829250122.USD","PPH","ULVR.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649986050","title":"AstraZeneca PLC Stock (AZN) Moved Down by 3.79% on Jul 6: What Signal Does It Send?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649986050","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649986050?lang=en_us&edition=fundamental","pubTime":"2026-07-06 23:15","pubTimestamp":1783350910,"startTime":"0","endTime":"0","summary":"• AstraZeneca partnered with CSPC Pharmaceutical in a deal valued up to $1.77 billion.\n• Shares declined due to profit-taking, earnings estimate revisions, and regulatory pipeline uncertainties.\n• Enhertu received European Commission approval for treating HER2-positive metastatic solid tumors.","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/AstraZeneca-000ba9f6d3d446b080935cd9fe1dade4.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262013530-market-movers-azn-20260706","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","AZN","LU2462157665.USD","LU0310800379.SGD","LU0432979614.USD","BK4585","LU2237443622.USD","LU2089984988.USD","BK4568","LU2456880835.USD","BK4007","LU2237443978.SGD","LU2237443895.HKD","LU0289739699.SGD","LU2417539215.USD","LU2237443549.SGD","IE00B3T34201.USD","LU0320765992.SGD","LU0708994859.HKD","LU0128525929.USD","LU2468319806.SGD","AZNH","LU2237443382.USD","LU1829250122.USD","LU2236285917.USD","BK4588","LU0029864427.USD","LU1267930573.SGD","LU0058720904.USD","LU2237443465.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649625436","title":"AstraZeneca (AZN) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2649625436","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649625436?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:45","pubTimestamp":1783334721,"startTime":"0","endTime":"0","summary":"In a report released today, Justin Smith from Bernstein maintained a Buy rating on AstraZeneca, with a price target of £189.00. According to TipRan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443465.HKD","LU2237443895.HKD","IE00B3T34201.USD","LU2237443549.SGD","BK4568","LU2237443382.USD","LU1267930573.SGD","LU2236285917.USD","LU2237443978.SGD","LU2468319806.SGD","AZNH","LU2417539215.USD","LU0320765992.SGD","LU2089984988.USD","LU0058720904.USD","BK4007","LU0109394709.USD","LU2456880835.USD","LU0708994859.HKD","LU0029864427.USD","AZN","LU2462157665.USD","LU0128525929.USD","LU0289739699.SGD","LU0889565916.HKD","LU0432979614.USD","LU0310800379.SGD","BK4585","BK4588","LU2237443622.USD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180905653","title":"CSPC Pharma Shares Surge Nearly 7% at Open on New $1.77 Billion Collaboration with AstraZeneca","url":"https://stock-news.laohu8.com/highlight/detail?id=1180905653","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180905653?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:45","pubTimestamp":1783043114,"startTime":"0","endTime":"0","summary":"Shares of CSPC Pharma (01093) climbed close to 7% in early trading. As of the latest update, the stock is up 4.64%, trading at HK$7.90 with a turnover of HK$237 million. The company announced it has...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","HK0000165453.HKD","IE0008369823.USD","LU1829250122.USD","BK1191","LU1267930573.SGD","LU2417539215.USD","LU0880133367.SGD","LU1328277881.USD","IE0008368742.USD","01093","LU1951186391.HKD","LU0289739699.SGD","AZNH","LU1960683339.HKD","LU2039709279.SGD","LU2089984988.USD","LU0314109678.HKD","IE00B543WZ88.USD","LU0708994859.HKD","BK4588","BK4007","LU2462157665.USD","LU1226288253.USD","LU1008478684.HKD","IE00BZ08YR35.GBP","BK4568","LU0501845795.SGD","LU0128525929.USD","LU0315179316.USD","BK1521","LU2468319806.SGD","LU1807302812.USD","LU0109394709.USD","LU1152091168.USD","LU1226287529.USD","AZN","LU0140636845.USD","BK1515","IE00B5MMRT66.SGD","LU0067412154.USD","BK4585","IE00BZ08YT58.USD","LU1226288170.HKD","LU2237443382.USD","LU1152091754.HKD","LU2237443622.USD","LU0029864427.USD","LU2237443978.SGD","LU2237443895.HKD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU0432979614.USD","LU0889565916.HKD","LU1226287792.SGD","LU0310800379.SGD","LU1993786604.SGD","LU0072913022.USD","LU1226287875.USD","LU2236285917.USD","LU2237443465.HKD","SG9999004220.SGD","LU0320765992.SGD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648687681","title":"Astrazeneca PLC Stock Rises Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2648687681","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648687681?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:00","pubTimestamp":1783008000,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC rose 4.9% to SEK1,881.00 Thursday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 1.1% to 2,734.14.The stock's rise  snapped a two-day losing streak.The company closed SEK44.50 below its 52-week high of SEK1,925.50, which the company achieved on April 10, 2026.Trading volume was 263,069, compared to the 50-day average trading volume of 284,734.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 02, 2026 12:00 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2237443465.HKD","LU0310800379.SGD","BK4588","BK4568","LU0320765992.SGD","LU2462157665.USD","LU0128525929.USD","LU0289739699.SGD","LU1267930573.SGD","LU0708994859.HKD","LU0058720904.USD","AZN","LU2237443382.USD","LU1829250122.USD","BK4585","LU2237443549.SGD","LU2237443622.USD","LU2417539215.USD","AZNH","LU2456880835.USD","LU2237443895.HKD","LU0432979614.USD","LU0029864427.USD","LU2237443978.SGD","LU0109394709.USD","LU2236285917.USD","BK4007","IE00B3T34201.USD","LU2468319806.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173197693","title":"Multiple Companies Announce Positive Developments: CSPC Pharma Partners with AstraZeneca, Digital China Wins Major Mobile Server Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=1173197693","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173197693?lang=en_us&edition=fundamental","pubTime":"2026-07-02 21:20","pubTimestamp":1782998437,"startTime":"0","endTime":"0","summary":"On the evening of July 2nd, numerous listed companies released a flurry of announcements detailing significant business developments.These disclosures spanned a wide range of sectors including...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK1515","IE00BZ08YS42.EUR","LU2237443465.HKD","000034","LU1008478684.HKD","LU1807302812.USD","IE00B5MMRT66.SGD","LU0310800379.SGD","BK4588","BK4568","LU0320765992.SGD","BK0250","LU0140636845.USD","LU0072913022.USD","LU1328277881.USD","LU2462157665.USD","LU0128525929.USD","IE0008368742.USD","LU0314109678.HKD","BK1191","LU0289739699.SGD","LU1267930573.SGD","LU0708994859.HKD","LU0058720904.USD","AZN","LU0880133367.SGD","LU2237443382.USD","HK0000165453.HKD","LU1226288170.HKD","LU1960683339.HKD","LU0501845795.SGD","LU1993786604.SGD","LU1829250122.USD","LU2468319806.SGD","SG9999004220.SGD","BK4585","LU2237443549.SGD","LU1226287875.USD","LU0326950275.SGD","LU1226287792.SGD","LU2237443622.USD","01093","LU2417539215.USD","AZNH","BK1521","LU0315179316.USD","IE00B031HY20.USD","LU1226288253.USD","LU2237443895.HKD","LU0432979614.USD","LU2456880835.USD","LU0029864427.USD","LU2237443978.SGD","IE00BZ08YR35.GBP","LU1152091168.USD","LU2039709279.SGD","BK0186","LU1951186391.HKD","IE00BZ08YT58.USD","LU0109394709.USD","LU2236285917.USD","BK4007","IE00B3T34201.USD","LU0067412154.USD","LU1813983027.USD","IE0008369823.USD","IE00B543WZ88.USD","LU1152091754.HKD","LU1226287529.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648502844","title":"AstraZeneca Collaborating With CSPC Pharma in siRNA Drug Deal Worth Up to $1.77 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2648502844","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648502844?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:43","pubTimestamp":1782992616,"startTime":"0","endTime":"0","summary":"AstraZeneca  has entered into a collaboration, option and license agreement with CSPC Pharmaceutical to develop small interfering RNA  therapies targeting kidney diseases, CSPC said Thursday.Under the agreement, the companies will jointly discover and develop preclinical candidates for two renal disease targets using CSPC's proprietary siRNA drug discovery and extrahepatic delivery platforms, it said.AstraZeneca will have the option to secure exclusive global or ex-China development and commercialization rights for each program, while CSPC will retain China rights to one candidate, it added.CSPC will receive a $30 million upfront payment and is eligible for up to $540 million in development milestones and up to $1.2 billion in sales milestones, plus single-digit royalties on annual net sales, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1267930573.SGD","LU2468319806.SGD","LU2237443465.HKD","LU0432979614.USD","LU2237443978.SGD","AZN","BK4007","LU0029864427.USD","LU2237443895.HKD","IE00B3T34201.USD","LU0128525929.USD","LU0289739699.SGD","LU0320765992.SGD","LU1829250122.USD","LU2236285917.USD","LU2456880835.USD","BK4588","BK4568","LU2237443382.USD","LU0058720904.USD","LU2237443622.USD","LU2089984988.USD","LU2417539215.USD","LU0109394709.USD","LU0708994859.HKD","LU0310800379.SGD","BK4585","LU0889565916.HKD","LU2237443549.SGD","LU2462157665.USD","AZNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132870129","title":"CSPC Innovation's Subsidiary Forges Strategic Alliance with AstraZeneca on Novel Extrabepatic siRNA Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1132870129","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132870129?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:56","pubTimestamp":1782982586,"startTime":"0","endTime":"0","summary":"CSPC Innovation Pharmaceutical Co.,Ltd. (ASX: 300765) has announced a significant strategic partnership.The company's controlling subsidiary, CSPC Group Jushi Biopharmaceutical Co., Ltd., has entered...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4585","LU0029864427.USD","AZNH","06978","IE00B3T34201.USD","LU2237443622.USD","LU0128525929.USD","LU2456880835.USD","LU0058720904.USD","AZN","LU2237443382.USD","LU2417539215.USD","LU0889565916.HKD","LU2237443978.SGD","LU0432979614.USD","BK1161","BK1574","LU1829250122.USD","LU2237443465.HKD","LU2089984988.USD","LU2462157665.USD","LU2237443549.SGD","BK4588","300765","LU1267930573.SGD","LU0289739699.SGD","LU0109394709.USD","LU2236285917.USD","LU2237443895.HKD","BK4007","159992","BK4568","BK0226","LU0708994859.HKD","LU0310800379.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648057094","title":"Astrazeneca to Collaborate With Abbisko Therapeutics for Potential Non-Small Cell Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2648057094","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648057094?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:10","pubTimestamp":1782979822,"startTime":"0","endTime":"0","summary":"Astrazeneca  agreed to enter into a strategic collaboration with Abbisko Therapeutics to jointly advance the clinical development of a therapeutic candidate for non-small cell lung cancer, the latter said late Wednesday.The phase 1/2 study will evaluate the safety and efficacy of Abbisko's oral small-molecule programmed death-ligand 1 inhibitor, lumipodlin, in combination with AstraZeneca's osimertinib, for the treatment of patients suffering from non-small cell lung cancer.The phase 2 study will be led by Abbisko, which will share responsibilities for the trial with AstraZeneca.The National Medical Products Administration cleared the investigational new drug application for the combination study on May 20.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZN","BK4588","LU2236285917.USD","LU0708994859.HKD","LU1829250122.USD","LENZ","LU0128525929.USD","LU1267930573.SGD","LU2417539215.USD","LU2237443978.SGD","LU0432979614.USD","LU0310800379.SGD","LU0058720904.USD","LU0889565916.HKD","LU0029864427.USD","LU0289739699.SGD","AZNH","LU2456880835.USD","LU2089984988.USD","BK4139","BK4007","IE00B3T34201.USD","LU0109394709.USD","LU2237443622.USD","LU2468319806.SGD","LU2462157665.USD","LU2237443382.USD","LU0320765992.SGD","LU2237443465.HKD","BK4539","LU2237443549.SGD","BK4585","LU2237443895.HKD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160054792","title":"Biotech Firm Forges Major International Alliance with AstraZeneca! The Market's Sole Hang Seng Innovation Drug ETF, Huatai-PineBridge, Sees Turnover Exceed 10 Billion for 9 Consecutive Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=1160054792","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160054792?lang=en_us&edition=fundamental","pubTime":"2026-07-02 13:21","pubTimestamp":1782969665,"startTime":"0","endTime":"0","summary":"A significant partnership announcement today may inject fresh upward momentum into the innovative drug sector. A leading Hong Kong-listed pharmaceutical company disclosed that its subsidiary has...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","159992","LU2468319806.SGD","LU2237443465.HKD","520500","LU0432979614.USD","LU2237443978.SGD","AZN","BK4007","LU0029864427.USD","LU2237443895.HKD","IE00B3T34201.USD","LU0128525929.USD","LU0289739699.SGD","LU0320765992.SGD","LU1829250122.USD","LU2236285917.USD","LU2456880835.USD","BK4588","BK4568","LU2237443382.USD","LU0058720904.USD","LU2237443622.USD","LU2089984988.USD","LU2417539215.USD","LU0109394709.USD","06978","LU0708994859.HKD","LU0310800379.SGD","BK1161","BK4585","LU0889565916.HKD","LU2237443549.SGD","LU2462157665.USD","AZNH","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179926123","title":"Abbisko-B Shares Surge Over 5% on Clinical Collaboration with AstraZeneca for NSCLC Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1179926123","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179926123?lang=en_us&edition=fundamental","pubTime":"2026-07-02 11:46","pubTimestamp":1782963970,"startTime":"0","endTime":"0","summary":"Shares of Abbisko-B (02256) rose more than 5% in morning trading. At the time of writing, the stock was up 5.49% to HK$11.33, with a turnover of HK$17.38 million.The move follows an announcement on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0310800379.SGD","LU2237443895.HKD","LU1829250122.USD","LU0289739699.SGD","IE00B3T34201.USD","LU2456880835.USD","BK4585","LU0889565916.HKD","LU0029864427.USD","LU0432979614.USD","LU2488822045.USD","LU2476274308.USD","IE00BPRC5H50.USD","BK4007","LU0708994859.HKD","LU0320765992.SGD","LU2237443382.USD","LU1267930573.SGD","02256","BK4588","LU2236285917.USD","LU0058720904.USD","IE00B543WZ88.USD","BK1161","LU0128525929.USD","LU0109394709.USD","LU2237443622.USD","LU2417539215.USD","LU2237443465.HKD","AZNH","LU2468319806.SGD","LU2237443978.SGD","LU2089984988.USD","BK4568","LU2476274720.SGD","VXUS","AZN","LU2237443549.SGD","LU2778985437.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648257886","title":"AstraZeneca, Abbisko Therapeutics enter strategic collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2648257886","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648257886?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:05","pubTimestamp":1782954308,"startTime":"0","endTime":"0","summary":"Abbisko Therapeutics announced that it has entered into a strategic collaboration agreement with AstraZeneca (AZN) to jointly advance the clinical ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-abbisko-therapeutics-enter-strategic-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-abbisko-therapeutics-enter-strategic-collaboration-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","LU2237443465.HKD","LU2089984988.USD","BK4007","IE00B3T34201.USD","LU0058720904.USD","LU0310800379.SGD","LU2462157665.USD","LU1829250122.USD","BK4588","LU2237443549.SGD","AZN","LU2237443978.SGD","LU0109394709.USD","LU2237443895.HKD","LENZ","LU2417539215.USD","BK4585","LU2456880835.USD","LU2468319806.SGD","LU0289739699.SGD","BK4139","LU2237443622.USD","LU0889565916.HKD","LU0029864427.USD","LU2237443382.USD","LU1267930573.SGD","BK4539","BK4568","LU0128525929.USD","LU0432979614.USD","LU2236285917.USD","AZNH","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162068813","title":"ABBISKO-B Unit Enters Strategic Collaboration with AstraZeneca for Clinical Study on First-in-Class Oral PD-L1 Inhibitor Combined with Tagrisso in Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1162068813","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162068813?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:11","pubTimestamp":1782951088,"startTime":"0","endTime":"0","summary":"ABBISKO Therapeutics, a subsidiary of ABBISKO-B (HKEX: 02256), has announced the signing of a strategic collaboration agreement with AstraZeneca PLC (LSE/STO/NYSE: AZN).The partnership aims to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","BK4585","LU0058720904.USD","BK4568","LU0432979614.USD","LU1169589451.USD","LU2236285917.USD","LU2462157665.USD","LU2237443895.HKD","LU2488822045.USD","LU0128525929.USD","BK4588","LU0310800379.SGD","IE00B543WZ88.USD","LU2237443978.SGD","BK4007","LU0029864427.USD","BK4023","AZNH","IE00B5MMRT66.SGD","LU2778985437.USD","LU1829250122.USD","LU2476274308.USD","LU1267930573.SGD","LU2417539215.USD","LU0289739699.SGD","BK1161","LU2237443622.USD","LU2456880835.USD","LU0889565916.HKD","AZN","LU0320765992.SGD","LU1169590202.USD","LU2468319806.SGD","LU2237443549.SGD","02256","IE00B3T34201.USD","LU0109394709.USD","LU0708994859.HKD","LU2237443465.HKD","PD","LU2089984988.USD","LU2237443382.USD","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648449415","title":"European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2648449415","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648449415?lang=en_us&edition=fundamental","pubTime":"2026-07-01 23:12","pubTimestamp":1782918724,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking sharply lower late Wednesday morning, falling 1.61% to 1,890.71 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet advertising firm Criteo  and biotech company Evaxion , which rose 3% and 2.9% respectively. They were followed by pharmaceutical company Novo Nordisk  and software firm SAP , which were up 2.6% and 2.4% respectively.The decliners from continental Europe were led by telecommunications company Ericsson  and pharmaceutical company Sanofi , which lost 2.6% and 2.3% respectively. They were followed by oil and gas company Eni  and brewing company Anheuser-Busch InBev , which fell 2.2% and 1.3% respectively.The gainers from the UK were led by software firm Endava  and biopharmaceutical company NuCana , which advanced 5.7% and 3.3% respectively. They were followed by insurance company Prudential  and educational publisher Pearson , which increased 2.6% and 2.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVAX","02378","NVO","LU2456880835.USD","LU1267930573.SGD","BK4009","LU0432979614.USD","PSO","BK4142","LU2236285917.USD","PUK","ERIC","LU2237443382.USD","LU2237443895.HKD","LU0109394709.USD","LU0058720904.USD","NVOX","LU0648005311.SGD","LU2468319806.SGD","BK4204","BK4585","LU0154236417.USD","BK4162","BK4554","LU2417539215.USD","TRIB","LU1829250122.USD","AZNH","LU1093756168.USD","LU0310800379.SGD","IE00BZ1G4Q59.USD","IE00BFMHRM44.USD","LU0128525929.USD","NVOH","LU2089984988.USD","DAVA","LU2237443549.SGD","BK4599","BK4082","LU0029864427.USD","LU2237443622.USD","IE00B3T34201.USD","BK4007","NCNA","BK4134","BK4201","BK4139","LU2462157665.USD","LU2237443978.SGD","BDRX","LU1093756325.SGD","IE00BFXG1179.USD","LU2237443465.HKD","LU0889565916.HKD","BK4020","IHG","LU0708994859.HKD","BK4532","CRTO","BK4613","BK4591","BK4515","BUD","AZN","BK4588","IE00BKVL7J92.USD","E","BK4023","LU0084288595.USD","BK4111","BK4528","BK4158","LU0320765992.SGD","BK4568","LU0289739699.SGD","SAP","SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648563642","title":"AstraZeneca’s ASCERTAIN Trial Wrap-Up: What Prostate Cancer Data Could Mean for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2648563642","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648563642?lang=en_us&edition=fundamental","pubTime":"2026-07-01 00:30","pubTimestamp":1782837009,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The ASCERTAIN study, officially titled “An Open-label, Randomised, Phase-I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-ascertain-trial-wrap-up-what-prostate-cancer-data-could-mean-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-ascertain-trial-wrap-up-what-prostate-cancer-data-could-mean-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4568","LU0029864427.USD","LU1829250122.USD","LU0310800379.SGD","LU2417539215.USD","LU2237443978.SGD","LU2237443465.HKD","BK4585","LU0708994859.HKD","LU0058720904.USD","IE00B3T34201.USD","LU0432979614.USD","BK4588","LU0320765992.SGD","LU2237443549.SGD","LU2462157665.USD","LU2456880835.USD","LU2237443382.USD","LU2236285917.USD","LU2237443895.HKD","LU0889565916.HKD","LU0289739699.SGD","ISBC","LU0109394709.USD","AZN","AZNH","LU0128525929.USD","LU1267930573.SGD","BK4007","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648568202","title":"Astrazeneca Slides Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2648568202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648568202?lang=en_us&edition=fundamental","pubTime":"2026-07-01 00:08","pubTimestamp":1782835680,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AstraZeneca PLC  slid 1.38% to GBP141.00 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index  rising 0.12% to 10,497.12.AstraZeneca PLC closed 10.37% short of its 52-week high of GBP157.32, which the company reached on February 18th.Trading volume totaled 2.2 million, compared to the 50-day average of 2.2 million.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 30, 2026 12:08 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","AZNH","LU0289739699.SGD","LU2462157665.USD","LU0029864427.USD","LU0320765992.SGD","LU2456880835.USD","LU0109394709.USD","LU2417539215.USD","LU2237443549.SGD","LU0708994859.HKD","BK4585","LU2236285917.USD","BK4588","LU0058720904.USD","LU0432979614.USD","BK4568","LU2237443622.USD","IE00B3T34201.USD","LU2237443465.HKD","LU0128525929.USD","LU0310800379.SGD","LU2237443978.SGD","LU0889565916.HKD","LU1829250122.USD","LU2237443382.USD","LU2237443895.HKD","LU1267930573.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647146552","title":"Astrazeneca Might Face Questions About Next Year's Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2647146552","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647146552?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:29","pubTimestamp":1782829740,"startTime":"0","endTime":"0","summary":"1428 GMT - AstraZeneca might have to address questions about its potential to expand profitability next year when it reports second-quarter results, Bank of America analysts say in a research note. The U.K. drugmaker is expected to report quarterly sales of $15.4 billion and core earnings per share of $2.51, according to Bank of America. AstraZeneca is likely to reiterate guidance for 2026, but the debate about its 2027 profit margin might kick off again, the analysts says. Consensus expectations point to a 160 basis-point expansion in AstraZeneca's core operating profit margin, but Bank of America is more cautious even if its sales estimate is above consensus, the analysts add. Shares fall 0.6%.  Dow Jones NewswiresJune 30, 2026 10:29 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","BK4585","AZN","LU0106831901.USD","LU0306806265.USD","LU1804176565.USD","LU1894683348.USD","BK4553","LU0868494617.USD","LU1883839398.USD","LU2417539215.USD","BK4568","LU0070302665.USD","LU0477156797.USD","IE00BFXG1179.USD","LU2596442595.SGD","LU0314106906.USD","LU1363072403.SGD","LU0321505868.SGD","LU1791807156.HKD","BAC","AZNH","IE00B3T34201.USD","LU0310800965.SGD","LU0477156953.USD","IE00BKVL7J92.USD","LU0149725797.USD","LU2129689431.USD","LU2237443382.USD","LU2237443622.USD","LU0256863811.USD","BK4534","LU0130103400.USD","LU0208291251.USD","LU0417517546.SGD","LU0683600562.USD","LU1035773651.USD","LU1280957306.USD","LU1880398554.USD","IE00BZ1G4Q59.USD","LU0128525929.USD","LU0128525689.USD","LU0130102774.USD","LU0130517989.USD","LU0310800379.SGD","LU0211331839.USD","LU1267930227.SGD","LU0053666078.USD","LU1201861249.SGD","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647153974","title":"Deutsche Bank  Remains a Sell on AstraZeneca (AZN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647153974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647153974?lang=en_us&edition=fundamental","pubTime":"2026-06-30 17:15","pubTimestamp":1782810931,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on AstraZeneca, with a price target of £115.00. Accordin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-remains-a-sell-on-astrazeneca-azn-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-remains-a-sell-on-astrazeneca-azn-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU2237443549.SGD","LU2456880835.USD","BK4118","IE00B3T34201.USD","LU1829250122.USD","LU1267930573.SGD","LU0289739699.SGD","AZNH","BK4566","LU0708994859.HKD","BK4588","BK4007","LU2462157665.USD","BK4552","BK4568","DB","LU0128525929.USD","LU0109394709.USD","AZN","LU2237443382.USD","LU2237443622.USD","LU2417539215.USD","BK4585","LU2237443978.SGD","LU0029864427.USD","LU2237443895.HKD","LU0432979614.USD","LU0889565916.HKD","LU2236285917.USD","LU0310800379.SGD","LU2237443465.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647837587","title":"AstraZeneca (AZN) Receives a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2647837587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647837587?lang=en_us&edition=fundamental","pubTime":"2026-06-30 13:55","pubTimestamp":1782798953,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Buy rating on AstraZeneca today and set a price target of £165.00. Gordon CFA covers the Healthcare ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0889565916.HKD","XBI","LU2417539215.USD","LU0109394709.USD","LU2456880835.USD","CFA","LU2462157665.USD","LU2237443465.HKD","LU1267930573.SGD","AZN","BK4581","LU0310800379.SGD","LU2236285917.USD","LU2237443622.USD","LU0320765992.SGD","LU0128525929.USD","BK4585","BK4588","LU0289739699.SGD","LU0708994859.HKD","BK4568","LU1829250122.USD","LU2237443549.SGD","LU2237443978.SGD","LU2237443382.USD","LU2237443895.HKD","LABU","XLV","LU0058720904.USD","IE00B3T34201.USD","LU0432979614.USD","LU0029864427.USD","AZNH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}